Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/00016356109043405 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cyclosporine-induced gingival overgrowth-Review.
Dermatol Ther
December 2022
Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, The University of Warmia and Mazury, Olsztyn, Poland.
Article Synopsis
- - Drug-induced gingival overgrowth (DIGO) is an adverse effect linked to medications like phenytoin, calcium channel blockers, and cyclosporine A, leading to severe gum problems and potential tooth loss.
- - The condition is associated with factors such as poor oral hygiene, and it mostly affects young males, especially children and adolescents.
- - Treatment options include removing tartar and irritants, with gingivectomy being a common surgical procedure for addressing DIGO symptoms.
Evaluation of Electrosurgery and Diode Laser in Gingival Depigmentation.
J Pharm Bioallied Sci
July 2022
Senior Lecturer, Department of Oral Medicine And Radiology, Pdm Dental College & Research Institute, Bahadurgarh, Jhajjar, Haryana, India.
Introduction: Gingival depigmentation is a surgical procedure done to eliminate or reduce gingival hyperpigmentation. Various techniques are employed such as scalpel de-epithelization, gingivectomy, electrosurgery, use of chemical agents, cryosurgery, and lasers. The present study was conducted to assess the efficacy of laser and electrosurgical procedure in reducing gingival pigmentation in terms of pain, wound healing, and recurrence of melanin pigmentation.
View Article and Find Full Text PDFTreatment of calcium channel blocker-induced gingival overgrowth without modifying medication.
BMJ Case Rep
January 2021
Department of Dentistry and Oral Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Gingival overgrowth is a common side effect of calcium channel blockers used in the treatment of cardiovascular diseases. While controversial, management includes discontinuing the calcium channel blocker. We report the case of a 66-year-old Japanese man with hypertension and type 2 diabetes mellitus who was diagnosed with severe periodontitis covering almost all the teeth.
View Article and Find Full Text PDFLamotrigine-Induced Gingival Enlargement: An Older Problem Due to a Newer Drug - A Rare Case Report.
Clin Adv Periodontics
June 2022
Department of Periodontology, Sri Ramakrishna Dental College and Hospital, Coimbatore, Tamil Nadu, India.
Introduction: Gingival enlargement (GE) due to anti-epileptic drugs (AEDs) shows a high prevalence rate. However, lamotrigine, a newer AED, has not shown to induce GE. The present case report describes a rare case of GE in a patient with epilepsy under lamotrigine therapy for the past 3 years.
View Article and Find Full Text PDFNifedipine induced gingival enlargement in an edentulous patient: a case report with one year follow up.
BMC Oral Health
December 2018
Department of Oral and Maxillofacial Surgery, College of Dentistry, King Khalid University, Abha, Kingdom of Saudi Arabia.
Background: Gingival enlargement due to calcium channel blockers is a common complaint reported by patients. It can be localized or generalized and can range from mild to severe, affecting patients appearance and function. Nifedipine induced gingival enlargement is noticed only in 10 % of patients and very few cases of Nifedipine induced gingival enlargement in an edentulous patient have been documented in the literature.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!